Researchers with the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins School of Medicine and four other institutions have developed a molecular test to identify the presence of brain tumors.
Johns Hopkins neurosurgeons are among the first in the U.S. to use magnetic resonance guided focused ultrasound, also known as MRgFUS, to investigate how it may be applied to ablate diseased tissue and traverse the blood-brain barrier.
The gel can reach areas that surgery might miss and current drugs struggle to reach to kill lingering cancer cells and suppress tumor growth.
Neurosurgeon David Lin discusses the benefits of artificial cervical disk replacement and microdiscectomy.
New study by Johns Hopkins researchers could significantly shorten monitoring time before epilepsy surgery and improve outcomes
Physicians and scientists within the institution bolster understanding in both fields, with the aim of enhancing patient care.
Two new models could solve a problem that’s long frustrated millions of people with epilepsy and the doctors who treat them: how to find precisely where seizures originate to treat exactly that part of the brain.
Johns Hopkins Medicine researchers have found a possible window of opportunity during ALS treatment to target astrocyte abnormalities — a subtype of cells in the central nervous system that provide a structure to metabolically support ...
Johns Hopkins neurosurgeon-scientists test a gamut of new therapeutic approaches — such as using bioengineered cancer cells to produce neoantigens that activate immune response. They simultaneously develop new tools and techniques to improve quality of life.
Spine neurosurgeons use technologies co-developed by faculty members to advance patient care. Plus, a first-of-its-kind lab creates a new class of implantable, wearable medical devices to aid those with spinal cord injuries.
Clinician-scientists develop technologies and conduct research to improve outcomes for patients with stroke globally, including integration of imaging, and clinical and genetic data to develop a precision medicine program.
Pediatric epileptologist Ahmad Marashly joins as multidisciplinary experts use new technologies and resources to provide potentially curative options for young patients. The program is among the few of its kind in the U.S.
Johns Hopkins researchers report that after 24 weeks of deep brain stimulation to a particular part of the organ, a patient’s long-experienced hallucinations and suspicious delusions entirely ceased.
Researchers at Johns Hopkins Medicine suggest there’s another role for the poor maligned adipose cell: a practical and plentiful source of stem cells for use in spinal fusion surgeries.
MRI scans of a patient’s brain showing the chronic active lesions (areas of localized damage marked by arrows within magnified insets) associated with multiple sclerosis (MS). Johns Hopkins Medicine and National Institute of Neurological ...
Patients diagnosed with idiopathic normal pressure hydrocephalus (iNPH), a type of brain swelling most commonly seen in older adults — and for which the underlying cause is unknown — are typically treated by surgically installing a shunt ...
By following certain patients for long periods — sometimes from childhood through adulthood — the Johns Hopkins epilepsy team helps protect patients from problems that can occur during various stages of their lives.
Some people may think nothing can be done for neurodegenerative disorders such as progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS). However, a Johns Hopkins Medicine researcher and his colleagues are adamant that is not the case.
Developed at Johns Hopkins, a next-generation technique helps neurologists identify hard-to-diagnose brain infections. Johns Hopkins is one of the few academic medical centers offering the approach in the U.S.
Two experimental drug approaches that target vulnerabilities in cancer cell metabolism may extend survival and enhance the effectiveness of standard chemotherapies for a highly aggressive type of pediatric brain cancer.
Johns Hopkins researchers continue study into brain stimulation — reinforced with repetitive learning strategies — to increase motor function after stroke. Findings could enable clinicians to develop approaches to reinforce learning, in ...
Johns Hopkins’ Cerebral Fluid Center is among the few in the United States that can diagnose and treat the full spectrum of such disorders.
In the spring of 2019, Peruvian neurologists saw a significant increase in the number of patients with Guillain-Barre syndrome (GBS). This rare disorder occurs when a person’s immune system damages the nerves, causing muscle weakness and sometimes paralysis.
Johns Hopkins neurosurgeons have performed the institution’s first augmented reality surgeries in living patients.
Johns Hopkins Medicine researchers and colleagues at the University of Maryland have found what is believed to be the first measurable physical evidence of diminished brain processing after a minor stroke.
For difficult epilepsy cases, Johns Hopkins experts use the latest, less invasive diagnostic and treatment tools.
Johns Hopkins neurosurgeons and biomedical engineers work to create wearable and implantable devices enabling continuous, postoperative treatment of acute, subacute and chronic spinal cord injury. The effort is funded by a $13.48 million ...
New study by Johns Hopkins Medicine neuroplastic and reconstructive surgeons under Chad Gordon shows “undercover” implant between scalp and skull successfully treats brain swelling known as hydrocephalus.
A recently published Johns Hopkins study — conducted in collaboration with the University of Cincinnati — shows how electrospun fibers could simultaneously dispense more than one chemotherapy agent to brain tumors.
Neuroplastic surgery represents a historic shift in approach, addressing the often stigmatizing physical side effects of neurosurgery.
New medication tested in clinical trials at Johns Hopkins and elsewhere shows dramatic results for patients with focal onset seizures.
Findings from medical records study could help doctors and patients make more informed treatment decisions
Under the care of experts at the Johns Hopkins Transverse Myelitis Center, a patient overcomes odds to walk again after rare and devastating neurological event.
New Johns Hopkins research suggests that blood pressure-lowering medicines can speed or inhibit bone healing.
Johns Hopkins neurosurgeons provide spina bifida patients new option to avoid ongoing detethering operations.
Hope may be on the horizon for epilepsy patients who have had limited success with seizure drugs.
Identifying ways to predict who will develop more severe multiple sclerosis.
Possible new drug targets for dementia and intellectual disability
The study, led by Johns Hopkins neurosurgeon-scientists, sheds light on the mechanisms involved in cancer and could lead to new treatments for olfactory neuroblastoma. Image shows cellular image of neuroblastoma.
By involving a rehabilitation psychologist and an expert on decreasing opioid use in patient care, the spine team aims to bolster the patient experience before and after surgery.
Neurofibromatosis Precision Medicine Center of Excellence works to mine untapped volumes of clinical data and use it for research that can benefit patients with neurofibromatosis.
Neurologic Winter 2019
News & Publications January 4, 2019
November 2, 2018
News & Publications
News Release February 2017
NeuroLogic Winter 2018
Recent News April 5, 2017
Recent News March 14, 2017
Pediatric NeuroNews December 16, 2016
Pediatric NeuroNews December 16, 2016
Press Release December 30, 2015
Insight December 1, 2015
Dome November 1, 2015
Insight September 2015
NeuroNow May 27, 2015